RNA interference by nanofiber-based siRNA delivery system

Journal of Controlled Release

Volumn 144, Issue 2, 2010, Pages 203-212

  Cao, Haoqing ^a   Jiang, Xu ^a   Chai, Chou ^b   Chew, Sing Yian ^a  

^a Nanyang Technological University   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Electrospinning; Nanofibrous scaffolds; Scaffold mediated transfection; SiRNA; Tissue engineering

Indexed keywords

BIOCHEMICAL SIGNAL; CELLULAR DEVELOPMENT; CELLULAR UPTAKE; CONTACT GUIDANCE; CONTROLLED RELEASE; DELIVERY VEHICLE; DIRECT-SEEDING; FIBROUS SCAFFOLDS; GENE SILENCING; GENETIC DISEASE; HEK293 CELLS; LABILE MOLECULES; NANOFIBROUS SCAFFOLDS; PHYSIOLOGICAL CONDITION; REGENERATIVE MEDICINE; RNA INTERFERENCE; SIRNA; SIRNA DELIVERY; SUSTAINED RELEASE; THERAPEUTIC AGENTS; TOPOGRAPHICAL FEATURES; TRANSFECTION REAGENTS;

ELECTROSPINNING; NANOFIBERS; NUCLEIC ACIDS; POLYCAPROLACTONE; RNA; TISSUE ENGINEERING;

SCAFFOLDS;

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MOLECULAR SCAFFOLD; NANOFIBER; POLYCAPROLACTONE; SMALL INTERFERING RNA;

ARTICLE; CELL STRAIN HEK293; CELL VIABILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; ENCAPSULATION; GENE DELIVERY SYSTEM; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA INTERFERENCE; SUSTAINED DRUG RELEASE;

ANIMALS; CELL LINE; GENE SILENCING; HUMANS; KIDNEY; MICE; NANOFIBERS; NANOPARTICLES; NIH 3T3 CELLS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 77952672525     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.02.003     Document Type: Article

References (46)

1. Kamath R.S., Fraser A.G., Dong Y., Poulin G., Durbin R., Gotta M., Kanapin A., Le Bot N., Moreno S., Sohrmann M., Welchman D.P., Zipperien P., Ahringer J. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 2003, 421:231-237.
2. Lum L., Yao S., Mozer B., Rovescalli A., Von Kessler D., Nirenberg M., Beachy P.A. Identification of Hedgehog pathway components by RNAi in Drosophila cultured cells. Science 2003, 299:2039-2045.
3. Berns K., Hijmans E.M., Mullenders J., Brummelkamp T.R., Velds A., Heimerikx M., Kerkhoven R.M., Madiredjo M., Nijkamp W., Weigelt B., Agami R., Ge W., Cavet G., Linsley P.S., Beijersbergen R.L., Bernards R. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 2004, 428:431-437.
4. Hu-Lieskovan S., Heidel J.D., Bartlett D.W., Davis M.E., Triche T.J. Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma. Cancer Res. 2005, 65:8984-8992.
5. Butz K., Ristriani T., Hengstermann A., Denk C., Scheffner M., Hoppe-Seyler F. siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene 2003, 22:5938-5945.
6. McCaffrey A.P., Nakai H., Pandey K., Huang Z., Salazar F.H., Xu H., Wieland S.F., Marion P.L., Kay M.A. Inhibition of hepatitis B virus in mice by RNA interference. Nat. Biotechnol. 2003, 21:639-644.
7. Vayssié L., Vargas M., Weber C., Guillén N. Double-stranded RNA mediates homology-dependant gene silencing of gamma-tubulin in the human parasite Entamoeba histolytica. Mol. Biochem. Parasitol. 2004, 138:21-28.
8. Singer O., Marr R.A., Rockenstein E., Crews L., Coufal N.G., Gage F.H., Verma I.M., Masliah E. Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nat. Neurosci. 2005, 8:1343-1349.
9. Miller V.M., Xia H., Marrs G.L., Gouvion C.M., Lee G., Davidson B.L., Paulson H.L. Allele-specific silencing of dominant disease genes. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:7195-7200.
10. Cheema S.K., Chen E., Shea L.D., Mathur A.B. Regulation and guidance of cell behavior for tissue regeneration via the siRNA mechanism. Wound Repair Regen. 2007, 15:286-295.
11. Aagaard L., Rossi J.J. RNAi therapeutics: principles, prospects and challenges. Adv. Drug Deliv. Rev. 2007, 59:75-86.
12. Sioud M., Sørensen D.R. Cationic liposome-mediated delivery of siRNAs in adult mice. Biochem. Biophys. Res. Commun. 2003, 312:1220-1225.
13. Howard K.A., Rahbek U.L., Liu X., Damgaard C.K., Glud S.Z., Andersen M.Ø., Hovgaard M.B., Schmitz A., Nyengaard J.R., Besenbacher F., Kjems J. RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. Mol. Ther. 2006, 14:476-484.
14. Eguchi A., Meade B.R., Chang Y.-C., Fredrickson C.T., Willert K., Puri N., Dowdy S.F. Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein. Nat. Biotechnol. 2009, 27:567-571.
15. Wolfrum C., Shi S., Jayaprakash K.N., Jayaraman M., Wang G., Pandey R.K., Rajeev K.G., Nakayama T., Charrise K., Ndungo E.M., Zimmermann T., Koteliansky V., Manoharan M., Stoffel M. Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nat. Biotechnol. 2007, 25:1149-1157.
16. Song E., Zhu P., Lee S.K., Chowdhury D., Kussman S., Dykxhoorn D.M., Feng Y., Palliser D., Weiner D.B., Shankar P., Marasco W.A., Lieberman J. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat. Biotechnol. 2005, 23:709-717.
17. Soutschek J., Akinc A., Bramlage B., Charisse K., Constien R., Donoghue M., Elbashir S., Gelck A., Hadwiger P., Harborth J., John M., Kesavan V., Lavine G., Pandey R.K., Racie T., Rajeev K.S., Röhl I., Toudjarska I., Wang G., Wuschko S., Bumcrot D., Kotellansky V., Limmer S., Manoharan M., Vornlocher H.P. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 2004, 432:173-178.
18. Bartlett D.W., Davis M.E. Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging. Nucleic Acids Res. 2006, 34:322-333.
19. Chun K.W., Lee J.B., Kim S.H., Park T.G. Controlled release of plasmid DNA from photo-cross-linked pluronic hydrogels. Biomaterials 2005, 26:3319-3326.
20. Jang J.H., Rives C.B., Shea L.D. Plasmid delivery in vivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection. Mol. Ther. 2005, 12:475-483.
21. Chew S.Y., Mi R., Hoke A., Leong K.W. The effect of the alignment of electrospun fibrous scaffolds on Schwann cell maturation. Biomaterials 2008, 29:653-661.
22. Chew S.Y., Mi R., Hoke A., Leong K.W. Aligned protein-polymer composite fibers enhance nerve regeneration: a potential tissue-engineering platform. Adv. Funct. Mater. 2007, 17:1288-1296.
23. Shin H., Jo S., Mikos A.G. Biomimetic materials for tissue engineering. Biomaterials 2003, 24:4353-4364.
24. Richardson T.P., Peters M.C., Ennett A.B., Mooney D.J. Polymeric system for dual growth factor delivery. Nat. Biotechnol. 2001, 19:1029-1034.
25. Luu Y.K., Kim K., Hsiao B.S., Chu B., Hadjiargyrou M. Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers. J. Control. Release 2003, 89:341-353.
26. Laabs T.L., Wang H., Katagiri Y., McCann T., Fawcett J.W., Geller H.M. Inhibiting glycosaminoglycan chain polymerization decreases the inhibitory activity of astrocyte-derived chondroitin sulfate proteoglycans. J. Neurosci. 2007, 27:14494-14501.
27. Chew S.Y., Wen Y., Dzenis Y., Leong K.W. The role of electrospinning in the emerging field of nanomedicine. Curr. Pharm. Des. 2006, 12:4751-4770.
28. Chew S.Y., Wen J., Yim E.K.F., Leong K.W. Sustained release of proteins from electrospun biodegradable fibers. Biomacromolecules 2005, 6:2017-2024.
29. Kenawy E.R., Bowlin G.L., Mansfield K., Layman J., Simpson D.G., Sanders E.H., Wnek G.E. Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend. J. Control. Release 2002, 81:57-64.
30. Gunatillake P.A., Adhikari R., Gadegaard N. Biodegradable synthetic polymers for tissue engineering. Eur. Cells Mater. 2003, 5:1-16.
31. Srikar R., Yarin A.L., Megaridis C.M., Bazilevsky A.V., Kelley E. Desorption-limited mechanism of release from polymer nanofibers. Langmuir 2008, 24:965-974.
32. Gandhi M., Srikar R., Yarin A.L., Megaridis C.M., Gemeinhart R.A. Mechanistic examination of protein release from polymer nanofibers. Mol. Pharm. 2009, 6:641-647.
33. Khan A., Benboubetra M., Sayyed P.Z., Ng K.W., Fox S., Beck G., Benter I.F., Akhtar S. Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies. J. Drug Target. 2004, 12:393-404.
34. Sanders L.M., Kell B.A., McRae G.I., Whitehead G.W. Prolonged controlled-release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: influence of composition and molecular weight of polymer. J. Pharm. Sci. 1986, 75:356-360.
35. Boury F., Marchais H., Proust J.E., Benoit J.P. Bovine serum albumin release from poly(α-hydroxy acid) microspheres: effects of polymer molecular weight and surface properties. J. Control. Release 1997, 45:75-86.
36. Luong-Van E., Grøndahl L., Chua K.N., Leong K.W., Nurcombe V., Cool S.M. Controlled release of heparin from poly(ε-caprolactone) electrospun fibers. Biomaterials 2006, 27:2042-2050.
37. Kim K., Luu Y.K., Chang C., Fang D., Hsiao B.S., Chu B., Hadjiargyrou M. Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds. J. Control. Release 2004, 98:47-56.
38. Zeng J., Aigner A., Czubayko F., Kissel T., Wendorff J.H., Greiner A. Poly(vinyl alcohol) nanofibers by electrospinning as a protein delivery system and the retardation of enzyme release by additional polymer coatings. Biomacromolecules 2005, 6:1484-1488.
39. Woodrow K.A., Cu Y., Booth C.J., Saucier-Sawyer J.K., Wood M.J., Saltzman W.M. Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA. Nat. Mater. 2009, 8:526-533.
40. Castanotto D., Sakurai K., Lingeman R., Li H., Shively L., Aagaard L., Soifer H., Gatignol A., Riggs A., Rossi J.J. Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC. Nucleic Acids Res. 2007, 35:5154-5164.
41. Khan A.A., Betel D., Miller M.L., Sander C., Leslie C.S., Marks D.S. Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs. Nat. Biotechnol. 2009, 27:549-555.
42. Segura T., Chung P.H., Shea L.D. DNA delivery from hyaluronic acid-collagen hydrogels via a substrate-mediated approach. Biomaterials 2005, 26:1575-1584.
43. Van Wachem P.B., Beugeling T., Feijen J. Interaction of cultured human endothelial cells with polymeric surfaces of different wettabilities. Biomaterials 1985, 6:403-408.
44. Lingor P., Michel U., Schöll U., Bähr M., Kügler S. Transfection of "naked" siRNA results in endosomal uptake and metabolic impairment in cultured neurons. Biochem. Biophys. Res. Commun. 2004, 315:1126-1133.
45. Hagstrom J.E., Hegge J., Zhang G., Noble M., Budker V., Lewis D.L., Herweijer H., Wolff J.A. A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs. Mol. Ther. 2004, 10:386-398.
46. Dorn G., Patel S., Wotherspoon G., Hemmings-Mieszczak M., Barclay J., Natt F.J., Martin P., Bevan S., Fox A., Ganju P., Wishart W., Hall J. siRNA relieves chronic neuropathic pain. Nucleic Acids Res. 2004, 32:e49.